The Prader-Willi and Angelman syndromes (PWS and AS) are neurogenetic disorders that are caused by the loss of function of imprinted genes on the proximal long arm of chromosome 15. 1 Deletions, uniparental disomy and imprinting defects, which account for most cases, can easily be detected by determining the DNA methylation pattern in proximal 15q. The best studied site is the promotor region of the SNRPN gene, which is methylated on the maternal chromosome and unmethylated on the paternal chromosome. 2 Initially, Southern blot analysis of DNA digested with methylation-sensitive restriction enzymes was used to study DNA methylation. In recent years, most laboratories have switched over to methylationspecific PCR (MS-PCR). 3 MS-PCR is based on the conversion of cytosine, but not 5-methyl-cytosine, to uracil by treatment with sodium bisulfite. By this, allelic methylation differences are converted into sequence differences, which can be detected by specific PCR reactions. Two different primer combinations are currently in use in most laboratories: Kubota et al 4 developed two specific primer pairs, one for the methylated maternal allele and the other for the unmethylated paternal allele. The reactions can be performed separately (simplex PCR) or in combination (duplex PCR). Zeschnigk et al 5 designed one common primer that anneals to both alleles and one specific primer each for the methylated and the unmethylated allele. The three primers are always used together in one reaction. Within the German external quality assessment scheme for the molecular diagnosis of PWS and AS, once a yearcoded DNA samples (5 -10 mg) from three core families are sent to laboratories in Germany, Austria and Switzerland. In 2001 and 2002, 17 and 22 labs, respectively, participated. The labs were asked to check the clinical diagnosis by a methylation test of their choice. Approximately 50% of the labs used the Kubota test and 50% used the Zeschnigk test. The original data and reports were evaluated by BH, CL, KB, JB and BJ.
In both years, one child was normal, one child had PWS and one child had AS. The 2001 PWS patient had uniparental disomy and the 2002 PWS patient had a deletion. Apart from one lab, which obtained a falsenegative result in the 2001 PWS patient, all labs found both alleles in the normal child and a methylated allele only in the patients with PWS (data not shown).
The two patients with AS had a sporadic imprinting defect without an IC deletion. As found by Southern blot analysis (Figure 1 ), the patients have a faint methylated band. This indicates that they are mosaic for an imprinting defect that occurred after fertilization. 6 In 2001 Table 1 , each of the labs reporting a false result had used the methylation test described by Kubota et al. Most of these labs had performed simplex reactions. Although some labs had also performed duplex reactions and obtained bands of unequal intensity, they were apparently misled by the presence of a strong PCR product in the simplex reactions. In contrast, all labs reporting the correct result had used the methylation test described by It is likely that amplification products from this allele, although under-represented in genomic DNA, are driven onto a plateau, because a specific primer pair for methylated DNA is used. The problem can be diminished by performing a duplex reaction. We note in this context that a commercially available kit for the Kubota test includes a protocol for simplex reactions only, although the original publication 4 describes simplex and duplex reactions. It should be noted that simplex reactions for the methylated and unmethylated alleles have another disadvantage in that a PCR failure in one tube will automatically lead to a false-positive result. In contrast to the Kubota test, the test described by Zeschnigk et al is based on a duplex PCR with one common primer, for which the two reactions compete. Thus, the test is semiquantitative and, as shown here, capable of detecting mosaic DNA methylation. Preliminary data suggest that methylation abnormalities can be detected even if the test sample contains up to 30% DNA from normal cells (Nazlican, Zeschnigk, Lich, Gillessen-Kaesbach, Buiting & Horsthemke, unpublished). However, exact degrees of methylation and limits of sensitivity can be determined by a quantitative study only (Nazlican et al., unpublished).
It has been suggested that the analysis of MS-PCR products by denaturing high-pressure liquid chromatography (DHPLC) is capable of detecting low cell mosaicism. 7 Since DHPLC was used by one lab only, our data do not allow assessment of this method. It should be noted, however, that this lab obtained a correct result in both AS patients, and that a small peak corresponding to methylated DNA was detected in the 2002 AS patient. Since 27% of patients with a sporadic-imprinting defect are mosaic for DNA methylation 6 and this group contains patients with an atypical phenotype that overlaps with PWS, 9 our results are highly relevant for diagnostic testing of patients suspected of having AS or PWS. Furthermore, mosaicism in AS and PWS can also be caused by other molecular mechanisms. It is worrying that more than 50% of the labs using the Kubota test obtained a false result. We strongly suggest the use of a duplex PCR (either according to Zeschnigk or to Kubota), and to carefully evaluate the relative intensities of the two bands. Owing to an MspI/HpaII restriction site polymorphism, which is irrelevant in this context, the unmethylated band is 0.9 or 0.5 kb. 10 All the three AS patients are heterozygous for this polymorphism. . In both tests, the amplification products of the methylated allele are larger than the amplification products of the unmethylated allele. m, simplex reaction with a primer pair specific for the methylated maternal allele; p, simplex reaction with a primer pair specific for the unmethylated paternal allele; mp, duplex reaction with both primer pairs. Note that both the m and p reactions of the Kubota test are positive in the AS-2002 patient. In the Kubota duplex reactions, the methylated band of the patient is slightly fainter compared to the methylated band in the normal individual. In the Zeschnigk test, the methylated band is very faint, and the pattern is clearly different from that of the normal control.
